Evoke Pharma (NASDAQ:EVOK) Share Price Passes Below 200-Day Moving Average of $0.87

Evoke Pharma, Inc. (NASDAQ:EVOK)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.87 and traded as low as $0.41. Evoke Pharma shares last traded at $0.49, with a volume of 10,780 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on Evoke Pharma in a research note on Saturday. They set a “sell” rating on the stock.

Evoke Pharma Stock Performance

The business’s 50 day simple moving average is $0.57 and its two-hundred day simple moving average is $0.86.

Evoke Pharma (NASDAQ:EVOK) last posted its quarterly earnings data on Thursday, March 14th. The specialty pharmaceutical company reported ($0.59) earnings per share for the quarter. Evoke Pharma had a negative net margin of 150.43% and a negative return on equity of 517.99%. The company had revenue of $1.68 million for the quarter.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.